BPA call - services for study involving labeling statements for a nonprescription drug product with an additional condition for nonprescription use (nsure)
Ended Awarded Last action
- Contract number
- 75F40121F19016
- Awardee
-
Research Triangle Institute UEI JJHCMK4NT5N3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $79,205
Award facts
- Contract value 100% obligated
- $79,205.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- B599 Special Studies/Analysis- Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$250,981 | |
| Supplemental Agreement for work within scope | $86,829 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $243,357 |
About this award
This is a firm fixed-price BPA call contract awarded by the Food and Drug Administration (FDA) to Research Triangle Institute (RTI International), a prominent non-profit research organization. The contract is for services to conduct a study involving labeling statements for a nonprescription drug product with an additional condition for nonprescription use, under the FDA's NSURE (Nonprescription Safe Use Regulatory Expansion) program. The award has a ceiling value of $79,205.30 and a period of performance through September 30, 2023. The contract is not set aside and is associated with RTI's existing Multiple Award Schedule (MAS) contract with the Environmental Protection Agency. RTI has a strong track record of delivering complex research and technical services to federal agencies, including the FDA, through both contract and grant awards.
Quick answers
Who was awarded contract 75F40121F19016?
75F40121F19016 was awarded to Research Triangle Institute by Food and Drug Administration (Department of Health and Human Services) on September 29, 2021.
How much is contract 75F40121F19016 worth?
The government has obligated $79,205 on 75F40121F19016.
Is contract 75F40121F19016 an order under another contract?
Yes. 75F40121F19016 is a BPA call under GS00F354CA-75F40120A00017, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40121F19016 competed?
The extent of competition for 75F40121F19016 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award